Egan Eye Associates | |
355 Stonebrook Parkway, Frisco, TX 75034 | |
(214) 432-4370 | |
Not Available |
Full Name | Egan Eye Associates |
---|---|
Type | Facility |
Speciality | Optometrist |
Location | 355 Stonebrook Parkway, Frisco, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053812685 | NPI | - | NPPES |
1912301342 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 8419TG (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Egan Eye Associates 3804 Riversdale Rd, Frisco, TX 75034-7611 Ph: (214) 432-4370 | Egan Eye Associates 355 Stonebrook Parkway, Frisco, TX 75034 Ph: (214) 432-4370 |
News Archive
The Diatron Group, a global provider of hematology and clinical chemistry analyzers, has launched a new version of its Abacus 3CT hematology analyzer. The new Abacus 3CT is a compact, bench-top, flexible 3-part differential analyzer which now offers 22 parameters to deliver even more patient data, and with its cap piercing capability, it can be used with sample tubes that are open or closed for greater convenience.
eClinicalWorks and Healthwise announced today an agreement to provide two Healthwise solutions to eClinicalWorks physician clients. Healthwise Information Therapy (Ix) Patient Instructions, take-home patient educational materials, integrates within the eClinicalWorks EMR; and the Healthwise Knowledgebase, an online health information library, has patient-specific connections within the eClinicalWorks secure Patient Portal.
Relaxing Covid-19 restrictions could pave the way for new vaccine-resistant virus mutations – according to researchers at the University of East Anglia and the Earlham Institute.
Medivation, Inc. and Astellas Pharma Inc. today announced treatment of the first patient in a second Phase 3 clinical trial of the investigational drug MDV3100, which expands the Phase 3 development of the novel, triple-acting oral androgen receptor antagonist into an earlier-stage patient population. Known as PREVAIL, the trial will evaluate MDV3100 in men with advanced prostate cancer who have not yet received chemotherapy. Initiation of the PREVAIL trial triggers a milestone payment to Medivation under its collaboration agreement with Astellas.
› Verified 2 days ago
Avant-garde Optometry Optometrist Medicare: Medicare Enrolled Practice Location: 9255 Dallas Pkwy, Suite 140, Frisco, TX 75034 Phone: 832-279-1881 | |
Top Vision Care Llc Optometrist Medicare: Medicare Enrolled Practice Location: 5999 Custer Rd Ste 120, Frisco, TX 75035 Phone: 217-819-2417 | |
Syeda Ghouse, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10760 Blackberry Ln, Frisco, TX 75033 Phone: 224-217-3606 | |
Stonebriar Vision Centre, P.a. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4851 Legacy Dr, Suite 305, Frisco, TX 75034 Phone: 972-377-4800 Fax: 214-705-6002 | |
Lindsey Willis Suelflow, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5858 W Main St, Suite 110, Frisco, TX 75033 Phone: 469-633-9339 | |
Dr. Felicia S Freeman, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6842 Lebanon Road, Suite #101, Frisco, TX 75034 Phone: 972-712-7890 Fax: 972-712-3119 |